Tina Dam Kristensen
Biographic Data
| ID | 7672997 |
|---|---|
| NAME | Tina Dam Kristensen |
| GIVEN NAMES | Tina Dam |
| FAMILY NAME | Kristensen |
| SIGNATURE | KRISTENSEN T D |
| AFFILIATIONS | Glostrup Hospital |
| ORCID | 0000-0001-9616-762X |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Subtle impairments of facial emotion expressions in individuals at ultra-high risk for psychosis
Emotional processing deficits are increasingly recognized as a salient feature of psychotic disorders, and emerging evidence suggests that impairments in facial emotion processing may serve as additive predictive markers for individuals at ultra-high risk (UHR) for psychosis, highlighting the importance of such deficits for early identification and intervention strategies. In this study we examined whether automated coding of facial features from…
Differential Effects of Aripiprazole and Amisulpride on Negative and Cognitive Symptoms in Patients With First-Episode Psychoses
Patients treated with aripiprazole improved on negative symptoms, which was not the case for patients treated with amisulpride. This may point to a general effect of a partial D2 receptor agonist on negative symptoms in patients with first-episode psychoses. There was, however, no improvement in cognitive functions
No Effects of Cognitive Remediation on Cerebral White Matter in Individuals at Ultra-High Risk for Psychosis—A Randomized Clinical Trial
ClinicalTrials.gov, identifier NCT02098408
No prominent works on this page.
No Effects of Cognitive Remediation on Cerebral White Matter in Individuals at Ultra-High Risk for Psychosis—A Randomized Clinical Trial
ClinicalTrials.gov, identifier NCT02098408
Differential Effects of Aripiprazole and Amisulpride on Negative and Cognitive Symptoms in Patients With First-Episode Psychoses
Patients treated with aripiprazole improved on negative symptoms, which was not the case for patients treated with amisulpride. This may point to a general effect of a partial D2 receptor agonist on negative symptoms in patients with first-episode psychoses. There was, however, no improvement in cognitive functions
Subtle impairments of facial emotion expressions in individuals at ultra-high risk for psychosis
Emotional processing deficits are increasingly recognized as a salient feature of psychotic disorders, and emerging evidence suggests that impairments in facial emotion processing may serve as additive predictive markers for individuals at ultra-high risk (UHR) for psychosis, highlighting the importance of such deficits for early identification and intervention strategies. In this study we examined whether automated coding of facial features from…
Clinical Psychology (2 works) · Clinical Psychology (2 works) · Cognition (2 works) · Medicine (2 works) · Psychiatry (2 works) · Psychology (2 works) · Psychosis (2 works) · Schizophrenia research and treatment (2 works) · Advanced Neuroimaging Techniques and Applications (1 work) · Amisulpride (1 work)